Ironwood Pharmaceuticals (IRWD) Other Non Operating Income (2011 - 2026)

Ironwood Pharmaceuticals' (IRWD) quarterly Other Non Operating Income came in at $42000.0 in Q1 2026, up 13.51% year-on-year from $37000.0 in Q1 2025, and down 45.45% quarter-over-quarter from $77000.0 in Q4 2025.

Ironwood Pharmaceuticals (IRWD) Other Non Operating Income (2011 - 2026) Analysis & Trends

Ironwood Pharmaceuticals has disclosed Other Non Operating Income across 6 years of filings, most recently posting $42000.0 for Q1 2026.

  • Other Non Operating Income for Q1 2026 came in at $42000.0, up 13.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $198000.0 (up 482.35% YoY), and the FY2025 annual result was $193000.0, down 69.84% from the prior year.
  • Other Non Operating Income came in at $42000.0 for Q1 2026 at Ironwood Pharmaceuticals, down from $77000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $77000.0 in Q4 2025 to a low of $37000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Ironwood Pharmaceuticals 526.31 Mn 305.84 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 42,000.00
Dec 31, 2025 77,000.00
Sep 30, 2025 40,000.00
Jun 30, 2025 39,000.00
Mar 31, 2025 37,000.00
Dec 31, 2020 -3,000.00
Mar 31, 2020 27,000.00
Dec 31, 2019 -31.19 Mn
Sep 30, 2019 -31.00 Mn
Jun 30, 2019 140,000.00
Mar 31, 2017 -2.01 Mn
Sep 30, 2011 897,000.00
Mar 31, 2011 3,000.00